X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (95467) 95467
Newsletter (7534) 7534
Book Chapter (840) 840
Newspaper Article (798) 798
Magazine Article (160) 160
Transcript (69) 69
Dissertation (58) 58
Conference Proceeding (45) 45
Book / eBook (35) 35
Publication (35) 35
Trade Publication Article (28) 28
Web Resource (19) 19
Book Review (3) 3
Reference (3) 3
Streaming Video (3) 3
Government Document (1) 1
Journal / eJournal (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (78067) 78067
science & technology (63673) 63673
life sciences & biomedicine (60085) 60085
male (40211) 40211
female (40042) 40042
oncology (39384) 39384
middle aged (33645) 33645
aged (31156) 31156
lung neoplasms - pathology (30681) 30681
lung cancer, non-small cell (26762) 26762
lung cancer (24218) 24218
lung neoplasms - drug therapy (23073) 23073
cancer (22854) 22854
carcinoma, non-small-cell lung - pathology (22800) 22800
adult (19991) 19991
carcinoma, non-small-cell lung - drug therapy (19166) 19166
prognosis (15268) 15268
research (14574) 14574
lung neoplasms - genetics (13653) 13653
neoplasm staging (13348) 13348
care and treatment (13036) 13036
cell line, tumor (12394) 12394
carcinoma, non-small-cell lung - genetics (12184) 12184
chemotherapy (12131) 12131
aged, 80 and over (11734) 11734
lung neoplasms - mortality (11730) 11730
animals (11367) 11367
non-small cell lung cancer (11201) 11201
respiratory system (10398) 10398
lung neoplasms - metabolism (10012) 10012
treatment outcome (9678) 9678
carcinoma, non-small-cell lung - mortality (9605) 9605
metastasis (9490) 9490
antineoplastic combined chemotherapy protocols - therapeutic use (9396) 9396
tumors (9336) 9336
lung neoplasms - surgery (8406) 8406
analysis (8379) 8379
non-small cell lung carcinoma (8103) 8103
carcinoma, non-small-cell lung - metabolism (8094) 8094
apoptosis (7831) 7831
mice (7755) 7755
retrospective studies (7701) 7701
oncology, experimental (7603) 7603
carcinoma, non-small-cell lung - surgery (7387) 7387
mutation (7319) 7319
genetic aspects (7094) 7094
gene expression (7016) 7016
lung neoplasms - therapy (6887) 6887
survival rate (6876) 6876
surgery (6849) 6849
abridged index medicus (6637) 6637
lung cancer, small cell (6614) 6614
antineoplastic agents - therapeutic use (6559) 6559
cell biology (6405) 6405
survival analysis (6368) 6368
lung neoplasms - radiotherapy (6344) 6344
cancer therapies (6188) 6188
proteins (6178) 6178
health aspects (6115) 6115
immunohistochemistry (5993) 5993
lung neoplasms - diagnosis (5724) 5724
patients (5624) 5624
gene expression regulation, neoplastic (5307) 5307
carcinoma, non-small-cell lung - radiotherapy (5074) 5074
carcinoma, non-small-cell lung - therapy (5025) 5025
cell proliferation (5009) 5009
carcinoma, small cell - pathology (4936) 4936
combined modality therapy (4911) 4911
development and progression (4847) 4847
kinases (4758) 4758
medical prognosis (4727) 4727
hematology, oncology and palliative medicine (4722) 4722
biochemistry & molecular biology (4611) 4611
research article (4549) 4549
radiotherapy (4499) 4499
follow-up studies (4424) 4424
adenocarcinoma - pathology (4377) 4377
respiratory tract diseases (4372) 4372
carcinoma, small cell - drug therapy (4324) 4324
nsclc (4216) 4216
medicine & public health (4154) 4154
small cell lung carcinoma (4143) 4143
carcinoma, non-small-cell lung - diagnosis (4139) 4139
signal transduction (4128) 4128
medicine (4083) 4083
pathology (4079) 4079
rna, small interfering - genetics (4078) 4078
lung neoplasms - diagnostic imaging (4051) 4051
disease-free survival (4040) 4040
pharmacology & pharmacy (4009) 4009
risk factors (3930) 3930
antineoplastic agents - pharmacology (3928) 3928
studies (3790) 3790
cisplatin - administration & dosage (3783) 3783
medical research (3775) 3775
carcinoma, squamous cell - pathology (3553) 3553
tumor cells, cultured (3539) 3539
radiology, nuclear medicine & medical imaging (3538) 3538
science & technology - other topics (3523) 3523
mice, nude (3513) 3513
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (99018) 99018
Japanese (2285) 2285
Chinese (2193) 2193
French (1324) 1324
German (1053) 1053
Spanish (478) 478
Russian (409) 409
Polish (312) 312
Italian (283) 283
Korean (164) 164
Portuguese (161) 161
Turkish (74) 74
Czech (71) 71
Dutch (71) 71
Hungarian (52) 52
Danish (45) 45
Norwegian (33) 33
Romanian (33) 33
Croatian (28) 28
Serbian (23) 23
Bulgarian (19) 19
Hebrew (16) 16
Swedish (12) 12
Finnish (11) 11
Slovak (9) 9
Lithuanian (7) 7
Icelandic (6) 6
Bosnian (4) 4
Slovenian (3) 3
Ukrainian (3) 3
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PloS one, ISSN 1932-6203, 08/2015, Volume 10, Issue 8, pp. e0136023 - e0136023
Background Immunotherapy can become a crucial therapeutic option to improve prognosis for lung cancer patients... 
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Adenocarcinoma - pathology | Prognosis | Follow-Up Studies | Lung Neoplasms - mortality | Carcinoma, Large Cell - pathology | Carcinoma, Squamous Cell - metabolism | Carcinoma, Squamous Cell - pathology | Humans | Lung Neoplasms - metabolism | Lung Neoplasms - pathology | Male | Carcinoma, Large Cell - mortality | Immunoenzyme Techniques | Adenocarcinoma - metabolism | Carcinoma, Squamous Cell - mortality | Neoplasm Grading | Biomarkers, Tumor - metabolism | Female | Retrospective Studies | Carcinoma, Non-Small-Cell Lung - pathology | Carcinoma, Large Cell - metabolism | Carcinoma, Non-Small-Cell Lung - metabolism | Carcinoma, Squamous Cell - therapy | Programmed Cell Death 1 Receptor - metabolism | Survival Rate | Combined Modality Therapy | Lung Neoplasms - therapy | Carcinoma, Non-Small-Cell Lung - mortality | B7-H1 Antigen - metabolism | Carcinoma, Non-Small-Cell Lung - therapy | Adenocarcinoma - therapy | Aged | Neoplasm Staging | Carcinoma, Large Cell - therapy | Adenocarcinoma - mortality | Care and treatment | Physiological aspects | Genetic aspects | Research | Lung cancer, Non-small cell | Apoptosis | Immunohistochemistry | Thoracic surgery | PD-1 protein | Lung cancer | Clinical trials | Oncology | Cancer therapies | Lymph nodes | Subgroups | Proteins | Rank tests | Regression models | Bcl-x protein | Lymphocytes | Immunotherapy | Medical research | Immunoglobulins | Squamous cell carcinoma | Cell survival | Cytokines | Hematology | Tumor cells | Non-small cell lung carcinoma | Breast cancer | Regression analysis | Patients | Medicine | Pathology | Chemotherapy | Hospitals | Cell death | Medical prognosis | PD-L1 protein | Ligands | Diagnostic systems | Solid tumors | Cancer | Tumors | Index Medicus
Journal Article
2000, Lung biology in health and disease, ISBN 0824702360, Volume 140., xx, 472
Book
PloS one, ISSN 1932-6203, 03/2013, Volume 8, Issue 3, pp. e57020 - e57020
.... Therapy resistance of a tumor is thought to be related to cancer stem cells (CSCs) within the tumors. There have been indications that the lung cancer is propagated and maintained by a small population of CSCs... 
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Adenocarcinoma - pathology | Adenocarcinoma of Lung | Cadherins - metabolism | Vimentin - metabolism | Carcinoma, Large Cell - pathology | Carcinoma, Squamous Cell - genetics | Carcinoma, Squamous Cell - metabolism | Carcinoma, Squamous Cell - pathology | Homeodomain Proteins - metabolism | Humans | Lung Neoplasms - metabolism | Gene Expression Regulation, Neoplastic | Lung Neoplasms - pathology | Antigens, CD - genetics | Antigens, CD - metabolism | Octamer Transcription Factor-3 - genetics | Small Cell Lung Carcinoma - metabolism | Adenocarcinoma - metabolism | Neoplastic Stem Cells - metabolism | Vimentin - genetics | Thy-1 Antigens - genetics | Hyaluronan Receptors - metabolism | Biomarkers, Tumor - metabolism | Neoplastic Stem Cells - pathology | Adenocarcinoma - genetics | Carcinoma, Large Cell - genetics | Cadherins - genetics | Lung Neoplasms - genetics | Carcinoma, Large Cell - metabolism | Nanog Homeobox Protein | Immunophenotyping | Small Cell Lung Carcinoma - genetics | Mice, SCID | Hyaluronan Receptors - genetics | Homeodomain Proteins - genetics | Thy-1 Antigens - metabolism | Small Cell Lung Carcinoma - pathology | Animals | Octamer Transcription Factor-3 - metabolism | Mice, Inbred NOD | Biomarkers, Tumor - genetics | Mice | Primary Cell Culture | Care and treatment | Analysis | Stem cells | Cancer cells | Physiological aspects | Research | Cancer | Adenocarcinoma | Vimentin | Cell culture | Therapy | Biotechnology | Thoracic surgery | Mesenchyme | Oct-4 protein | Lung cancer | Radiation | Population studies | Identification | Biology | mRNA | Metastasis | Cancer therapies | CD90 antigen | N-Cadherin | Immunology | CD44 antigen | Population | Medical research | Squamous cell carcinoma | Hematology | Small cell lung carcinoma | Cell division | Tumor cell lines | Gene expression | Cadherin | Spheroids | Morbidity | Medicine | Pathology | Lungs | Medical prognosis | Pancreatic cancer | Irradiation | Prostate | Tumors | Index Medicus
Journal Article
Cancer research (Chicago, Ill.), ISSN 1538-7445, 07/2017, Volume 77, Issue 13, pp. 3540 - 3550
.... In this study, we evaluated tumor specimens from 65 patients with melanoma, lung nonsquamous, squamous cell lung or head and neck cancers who were treated with the approved PD1-targeting antibodies... 
Life Sciences & Biomedicine | Oncology | Science & Technology | Gene Expression - drug effects | Carcinoma, Squamous Cell - genetics | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Antibodies, Monoclonal - therapeutic use | Lung Neoplasms - pathology | Male | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Squamous Cell Carcinoma of Head and Neck | Melanoma - genetics | Gene Expression - immunology | Aged, 80 and over | Adult | Female | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Antibodies, Monoclonal, Humanized - therapeutic use | Carcinoma, Non-Small-Cell Lung - genetics | Head and Neck Neoplasms - drug therapy | Gene Expression Profiling - methods | Melanoma - pathology | Head and Neck Neoplasms - pathology | Carcinoma, Non-Small-Cell Lung - immunology | Lung Neoplasms - immunology | Carcinoma, Squamous Cell - drug therapy | Melanoma - immunology | Melanoma - drug therapy | Nivolumab | Head and Neck Neoplasms - genetics | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Programmed Cell Death 1 Receptor - immunology | Programmed Cell Death 1 Receptor - genetics | PD-1 protein | CD8 antigen | Antibodies | Lymphocytes T | Killer cells | Cell activation | Lymphocytes | Natural killer cells | Signatures | Immune system | Squamous cell carcinoma | Head | Immune response | Small cell lung carcinoma | Tumor-infiltrating lymphocytes | Melanoma | Lung carcinoma | Gene expression | Ribonucleic acid--RNA | Patients | CD4 antigen | Immune checkpoint | Reproducibility | PD-L1 protein | Biomarkers | Head and neck cancer | Interferon | Solid tumors | Cancer | Tumors | Index Medicus
Journal Article
The New England journal of medicine, ISSN 1533-4406, 11/2019, Volume 381, Issue 21, pp. 2020 - 2031
Patients with advanced non–small-cell lung cancer with a PD-L1 expression level of 1... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Antineoplastic Agents, Immunological - administration & dosage | Lung Neoplasms - drug therapy | Lung Neoplasms - mortality | Humans | Lung Neoplasms - metabolism | Middle Aged | Carcinoma, Non-Small-Cell Lung - metabolism | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Ipilimumab - adverse effects | Nivolumab - adverse effects | Carcinoma, Non-Small-Cell Lung - mortality | Antineoplastic Agents, Immunological - adverse effects | B7-H1 Antigen - metabolism | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Survival Analysis | Aged, 80 and over | Adult | Female | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Ipilimumab - administration & dosage | Nivolumab - administration & dosage | Lung cancer, Non-small cell | Drug therapy | Patient outcomes | Ipilimumab | Testing | Small cell lung carcinoma | Lung cancer | Non-small cell lung carcinoma | Oncology | Cancer therapies | Chemotherapy | Immunotherapy | PD-L1 protein | Biomarkers | Clinical medicine | Mutation | Drug dosages | Apoptosis | Tumors | Index Medicus | Abridged Index Medicus | B7-H1 Antigen | Carcinoma, Non-Small-Cell Lung | Antineoplastic Combined Chemotherapy Protocols | Cellular Biology | Lung Neoplasms | Life Sciences | Antineoplastic Agents, Immunological | Nivolumab
Journal Article
The New England journal of medicine, ISSN 1533-4406, 08/2017, Volume 377, Issue 9, pp. 829 - 838
...–small-cell lung cancer. Importantly, it reduced the risk of CNS relapse. 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Lung Neoplasms - drug therapy | Pyrazoles - therapeutic use | Follow-Up Studies | Lung Neoplasms - mortality | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Protein Kinase Inhibitors - adverse effects | Central Nervous System Neoplasms - secondary | Young Adult | Pyridines - adverse effects | Anaplastic Lymphoma Kinase | Antineoplastic Agents - adverse effects | Aged, 80 and over | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Adult | Female | Receptor Protein-Tyrosine Kinases - analysis | Pyrazoles - adverse effects | Pyridines - therapeutic use | Crizotinib | Carbazoles - adverse effects | Kaplan-Meier Estimate | Carcinoma, Non-Small-Cell Lung - mortality | Disease-Free Survival | Animals | Piperidines - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Piperidines - adverse effects | Intention to Treat Analysis | Carbazoles - therapeutic use | Carcinoma, Non-Small-Cell Lung - drug therapy | Central Nervous System Neoplasms - drug therapy | Drugs | Care and treatment | Analysis | Comparative analysis | Lung cancer, Non-small cell | Health aspects | Systemic diseases | Toxicity | Lung cancer | Central nervous system | Non-small cell lung carcinoma | Oncology | Nervous system | Metastasis | Radiation therapy | Patients | Lymphoma | Cancer therapies | Survival | Mutation | Protein-tyrosine kinase | Drug dosages | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
International journal of radiation oncology, biology, physics, ISSN 0360-3016, 11/2014, Volume 90, Issue 4, pp. 834 - 842
...) in stage III non-small cell lung cancer (NSCLC). Methods and Materials We retrospectively reviewed 91 cases with stage III NSCLC treated with definitive chemoradiation therapy... 
Radiology | Hematology, Oncology and Palliative Medicine | Oncology | Life Sciences & Biomedicine | Radiology, Nuclear Medicine & Medical Imaging | Science & Technology | Carcinoma, Non-Small-Cell Lung - radiotherapy | Lung Neoplasms - drug therapy | Risk Assessment - methods | Adenocarcinoma - pathology | Prognosis | Follow-Up Studies | Lung Neoplasms - mortality | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Lung Neoplasms - radiotherapy | Tomography, X-Ray Computed - methods | Lung Neoplasms - pathology | Male | Carcinoma, Squamous Cell - diagnostic imaging | Carcinoma, Squamous Cell - radiotherapy | Chemoradiotherapy | Carcinoma, Squamous Cell - mortality | Karnofsky Performance Status | Female | Radiotherapy Planning, Computer-Assisted | Adenocarcinoma - radiotherapy | Carcinoma, Non-Small-Cell Lung - pathology | Reproducibility of Results | Movement | Induction Chemotherapy - methods | Proportional Hazards Models | Adenocarcinoma - drug therapy | Carcinoma, Non-Small-Cell Lung - mortality | Carcinoma, Squamous Cell - drug therapy | Contrast Media | Lung Neoplasms - diagnostic imaging | Aged | Carcinoma, Non-Small-Cell Lung - diagnostic imaging | Adenocarcinoma - diagnostic imaging | Carcinoma, Non-Small-Cell Lung - drug therapy | Exhalation | Neoplasm Staging | Adenocarcinoma - mortality | Sects | Lung cancer, Small cell | Physicists | Lung cancer, Non-small cell | Index Medicus | REVIEWS | PATIENTS | IMAGE PROCESSING | NEOPLASMS | LUNGS | METASTASES | RADIOLOGY AND NUCLEAR MEDICINE | CLASSIFICATION | COMPARATIVE EVALUATIONS | CAT SCANNING | HAZARDS
Journal Article
International journal of radiation oncology, biology, physics, ISSN 0360-3016, 08/2014, Volume 89, Issue 5, pp. 1084 - 1091
.... We sought to investigate the mechanisms underlying radiation-induced lymphopenia and its associations with patient outcomes in non-small cell lung cancer (NSCLC... 
Radiology | Hematology, Oncology and Palliative Medicine | Oncology | Life Sciences & Biomedicine | Radiology, Nuclear Medicine & Medical Imaging | Science & Technology | Carcinoma, Non-Small-Cell Lung - radiotherapy | Lung Neoplasms - drug therapy | Adenocarcinoma - pathology | Lung Neoplasms - mortality | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Lung Neoplasms - radiotherapy | Lung Neoplasms - pathology | Male | Carcinoma, Squamous Cell - radiotherapy | Lymphopenia - etiology | Lymphopenia - mortality | Carcinoma, Squamous Cell - mortality | Aged, 80 and over | Adult | Female | Lung - radiation effects | Adenocarcinoma - radiotherapy | Lymphopenia - diagnosis | Carcinoma, Non-Small-Cell Lung - pathology | Radiotherapy Dosage | Lung - pathology | Treatment Outcome | Tumor Burden | Adenocarcinoma - drug therapy | Carcinoma, Non-Small-Cell Lung - mortality | Carcinoma, Non-Small-Cell Lung - immunology | Disease-Free Survival | Regression Analysis | Lung Neoplasms - immunology | Carcinoma, Squamous Cell - drug therapy | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Adenocarcinoma - mortality | Care and treatment | Patient outcomes | Immunotherapy | Lung cancer, Small cell | Lung cancer, Non-small cell | Lymphocytopenia | Tumors | Chemotherapy | Lymphocytes | Analysis | Radiation | Cancer | Index Medicus | PATIENTS | LYMPHOPENIA | NEOPLASMS | LUNGS | MONOCYTES | NEUTROPHILS | CORRELATIONS | RADIATION DOSES | CHEMOTHERAPY | MULTIVARIATE ANALYSIS | RADIOLOGY AND NUCLEAR MEDICINE | RADIOTHERAPY | LYMPHOCYTES
Journal Article